Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
US think tank: Trump has signed more executive orders in less than a year since returning to the White House than during his first term combined.

US think tank: Trump has signed more executive orders in less than a year since returning to the White House than during his first term combined.

CointimeCointime2025/12/17 17:51

according to the latest data from the Pew Research Center, in less than a year since Trump’s return to the White House, the number of executive orders he has signed has already exceeded the total number during his entire first term from 2017 to 2021. Trump signed dozens of executive orders at an unprecedented pace in the first few days of his second term and has continued to work tirelessly since then. According to the Federal Register, Trump has currently signed 221 executive orders, surpassing the 220 signed during his four-year first term. In comparison, Biden signed only 162 during his four-year term. The Pew Research Center points out that if Trump maintains his current pace, the records of his predecessors may be far left behind by the end of his four-year term.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Laser uranium enrichment technology developer LIS Technologies (LIS.US) sets IPO price at $5-7 per share, aiming to raise $17 million

LIS Technologies plans to issue 2.8 million shares at a price range of $5 to $7 per share to raise $17 million.

智通财经•2026/10/27 07:27
Laser uranium enrichment technology developer LIS Technologies (LIS.US) sets IPO price at $5-7 per share, aiming to raise $17 million

Immunology and inflammation biotech company Bambusa (BBTX.US) prices IPO at $15-17 per share, aims to raise $150 million.

Bambusa Therapeutics plans to raise 150 millions USD by issuing 9.4 million shares at a price range of 15 to 17 USD per share.

智通财经•2026/10/27 07:21

The Bank of Japan’s price trend indicator rises above 3%, providing grounds for further rate hikes

The Bank of Japan's indicator for measuring underlying inflation has risen to its highest level in three years, far surpassing the bank's 2% target, providing grounds for authorities to continue raising interest rates.

智通财经•2026/10/27 07:17
The Bank of Japan’s price trend indicator rises above 3%, providing grounds for further rate hikes

$95 billion bet on AI! Meta (META.US) launches rare equity financing, while Goldman Sachs still maintains "Buy" rating

Meta announced a $95 billion equity financing, with NVIDIA, AMD, and Broadcom planning to subscribe $5 billion. Goldman Sachs reiterated its "buy" rating with a target price of $885.

智通财经•2026/10/27 07:07